TECLens, Inc.-preview

Teclens

TECLens, Inc.

Private

Stamford, ConnecticutHealthcare & Life Scienceshttps://teclens.com/

Last Round

Series A

Feb 11, 2025

Total Funding Raised

$9.3M

Momentum Score

50 /100

Company Overview

TECLens, Inc. is a medical device company developing a non-invasive, personalized corneal cross-linking technology for vision correction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Hardware + Subscription

AI Layer

Non-AI

Keywords

corneal cross-linkingqCXLCXLnon-invasive vision correctionpresbyopia treatmentCXLens systemLASIK alternativeophthalmic medical devicecorneal reshapingrefractive error correctionreal-time ultrasound monitoringreading glasses alternativekeratoconus treatmentmyopia treatmentmedical device sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TECLens, Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TECLens, Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 11, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Thomas Dunlap

Chief Executive Officer

Executive Team

Rob Hughes

CFO

Executive Team

Patrick Lopath

Chief Operating Officer

Executive Team

TECLens, Inc. Investors

Notable investors and investment history

Investor	Rounds
Yonjin Capital	Series A
Rimonci	Series A
Johnson & Johnson Innovation - JJDC, Inc.	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 11, 2025
Monthly visitors grew 97% MoM, reaching 1.9K.
May 2, 2025
Monthly visitors increased 147% MoM.

View all signals

TECLens, Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TECLens, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TECLens, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersStamford, Connecticut

Employee Range12

Year Founded2013

Last FundingFeb 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.